Susquehanna International Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Sell |
203,809
-763,942
| -79% | -$8.85M | ﹤0.01% | 2095 |
|
|
2025
Q1 | $8.45M | Buy |
967,751
+879,491
| +996% | +$7.68M | ﹤0.01% | 747 |
|
|
2024
Q4 | $1.27M | Buy |
88,260
+33,666
| +62% | +$483K | ﹤0.01% | 2649 |
|
|
2024
Q3 | $1.23M | Sell |
54,594
-36,487
| -40% | -$824K | ﹤0.01% | 2421 |
|
|
2024
Q2 | $1.77M | Buy |
91,081
+53,219
| +141% | +$1.04M | ﹤0.01% | 1883 |
|
|
2024
Q1 | $1.42M | Sell |
37,862
-14,192
| -27% | -$533K | ﹤0.01% | 2215 |
|
|
2023
Q4 | $2.91M | Buy |
52,054
+41,177
| +379% | +$2.3M | ﹤0.01% | 1574 |
|
|
2023
Q3 | $449K | Buy |
+10,877
| New | +$449K | ﹤0.01% | 3568 |
|
|
2023
Q2 | – | Sell |
-3,911
| Closed | -$218K | – | 6473 |
|
|
2023
Q1 | $218K | Sell |
3,911
-3,548
| -48% | -$198K | ﹤0.01% | 4776 |
|
|
2022
Q4 | $272K | Sell |
7,459
-73,518
| -91% | -$2.68M | ﹤0.01% | 4032 |
|
|
2022
Q3 | $2.31M | Buy |
80,977
+66,028
| +442% | +$1.88M | ﹤0.01% | 1529 |
|
|
2022
Q2 | $676K | Buy |
+14,949
| New | +$676K | ﹤0.01% | 2960 |
|
|
2022
Q1 | – | Sell |
-42,291
| Closed | -$6.3M | – | 6531 |
|
|
2021
Q4 | $6.3M | Buy |
42,291
+1,346
| +3% | +$201K | ﹤0.01% | 1041 |
|
|
2021
Q3 | $5.96M | Buy |
40,945
+25,956
| +173% | +$3.78M | ﹤0.01% | 1048 |
|
|
2021
Q2 | $2.94M | Buy |
14,989
+11,460
| +325% | +$2.24M | ﹤0.01% | 1703 |
|
|
2021
Q1 | $639K | Sell |
3,529
-34,615
| -91% | -$6.27M | ﹤0.01% | 3556 |
|
|
2020
Q4 | $5.4M | Buy |
+38,144
| New | +$5.4M | ﹤0.01% | 955 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5000 |
|
|
2020
Q2 | – | Sell |
-24,833
| Closed | -$1.55M | – | 4949 |
|
|
2020
Q1 | $1.55M | Buy |
24,833
+20,404
| +461% | +$1.27M | ﹤0.01% | 1532 |
|
|
2019
Q4 | $338K | Sell |
4,429
-5,980
| -57% | -$456K | ﹤0.01% | 3049 |
|
|
2019
Q3 | $525K | Buy |
+10,409
| New | +$525K | ﹤0.01% | 2859 |
|